Dashboard
Manage Tickers

PCSAProcessa Pharmaceuticals, Inc.


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
$ 1.28 - $ 18.00
4,338
na
4.62M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

processa-pharma-q2-eps-101-beats-102-estimate
Processa Pharma Q2 EPS $(1.01) Beats $(1.0...
08/28/2024 12:11:55

Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate of $(1.0...

hc-wainwright--co-reiterates-buy-on-processa-pharma-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on Proc...
08/20/2024 10:54:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 pric...

processa-pharmaceuticals-reports-preclinical-data-for-ngc-iri-delivers-more-cancer-killing-sn-38-molecules-to-tumor-than-irinotecan-and-onivyde-studies-support-potential-benefit-as-an-improved-treatment-with-fewer-side-effects
Processa Pharmaceuticals Reports Preclinic...
08/19/2024 12:02:46

Delivers more cancer-killing SN-38 molecules to tumor than irinotecan and Onivyde®Studies support potential benefit as an impro...

hc-wainwright--co-maintains-buy-on-processa-pharma-lowers-price-target-to-6
HC Wainwright & Co. Maintains Buy on Proce...
08/19/2024 11:15:16

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharma (NASDAQ:PCSA) with a Buy and lowers the price t...

hc-wainwright--co-reiterates-buy-on-processa-pharma-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Proc...
08/01/2024 10:22:48

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $8 pric...

nasdaq-down-1-jetblue-airways-shares-spike-higher
Nasdaq Down 1%; JetBlue Airways Shares Spi...
07/30/2024 18:31:01

why-merck-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Merck Shares Are Trading Lower By 10%?...
07/30/2024 17:53:26

crude-oil-down-1-procter--gamble-shares-fall-after-q4-results
Crude Oil Down 1%; Procter & Gamble Shares...
07/30/2024 16:16:27

dow-jumps-200-points-pfizer-earnings-top-views
Dow Jumps 200 Points; Pfizer Earnings Top ...
07/30/2024 14:12:54

processa-pharmaceuticals-announces-fda-clearance-of-ind-application-for-a-phase-2-clinical-trial-of-ngc-cap-in-breast-cancer
Processa Pharmaceuticals Announces FDA Cle...
07/30/2024 12:06:58

Open-label Phase 2 trial in breast cancer to begin this quarterInitial data expected mid-2025HANOVER, Md., July 30, 2024 (GLOBE...

processa-pharmaceuticals-appoints-russell-l-skibsted-as-cfo
Processa Pharmaceuticals Appoints Russell ...
07/17/2024 12:13:18

hc-wainwright--co-reiterates-buy-on-processa-pharma-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Proc...
06/12/2024 10:56:47

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $8 pric...

processa-pharmaceuticals-shares-are-trading-higher-after-the-company-announced-efficacy-results-from-a-preliminary-evaluation-of-its-phase-1b-dose-escalating-trial-with-ngc-cap-in-gastrointestinal-cancer
Processa Pharmaceuticals shares are tradin...
06/11/2024 12:27:41

processa-pharmaceuticals-announces-results-from-phase-1b-trial-of-next-generation-capecitabine-for-stage-iiiiv-gi-cancer-establishing-maximum-tolerated-dose-and-recommended-phase-2-dose-range
Processa Pharmaceuticals Announces Results...
06/11/2024 12:21:09

Eight of 12 evaluable patients (66.7%) had progression-free survival (PFS) ranging from 5 to 11 monthsAt the highest NGC-Cap do...

processa-pharmaceuticals-files-base-prospectus-for-up-to-50m-in-securities-covers-up-to-24m-of-common-stock-to-be-issued-and-sold-under-sales-agreement-with-agpalliance-global-partners
Processa Pharmaceuticals Files Base Prospe...
05/21/2024 20:14:37

hc-wainwright--co-reiterates-buy-on-processa-pharma-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Proc...
05/13/2024 12:00:07

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $8 pric...

why-aon-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Aon Shares Are Trading Lower By Around...
04/26/2024 17:56:57

why-alphabet-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket
Why Alphabet Shares Are Trading Higher By ...
04/26/2024 12:18:32

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/26/2024 12:06:32

crude-oil-moves-higher-bristol-myers-squibb-shares-fall-after-q1-results
Crude Oil Moves Higher; Bristol Myers Squi...
04/25/2024 18:32:33

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION